CD47 and cancer: SFRs can work in combination with the CD47 pathway but function independently of CD47 to mitigate macrophage phagocytosis.163 SLAMF3 is also expressed in cancer cells,164 but its function in phagocytosis in cancer immunotherapy remains unclear.